Trial Profile
A Phase II, non-randomised study of trilostane in pre-menopausal women with positive oestrogen positive breast cancer who have relapsed or are resistant to treatment with previous hormone therapies
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 19 May 2006
Price :
$35
*
At a glance
- Drugs Trilostane (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 19 May 2006 New trial record.